Yaneng Bio is a company dedicated to gene chip technology. The company has developed a practical gene chip diagnostic technology platform, mainly engaged in gene diagnostic chip series products, thalassemia products, cervical cancer screening series products, etc., which are widely used by many hospitals and medical institutions across the country. Recently completed strategic financing, the investor is Cambridge Capital. FA is Ekai Capital.
This article is reproduced from: https://www.itjuzi.com/investevent/13199483
This site is for inclusion only, and the copyright belongs to the original author.